Publication | Closed Access

The PPARγ agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus

Molecular PharmacologyPilocarpine-induced Status EpilepticusSynaptic SignalingNeurophysiologyMedicineNeuropharmacologyNeuroprotectionNeurologyNeuroscienceMolecular NeurobiologyPharmacologyNeurochemistryAstrocyte ActivationSocial SciencesOxidative Stress